Clover Health Investments, Corp (CLOV) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 15, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CLOV SEC filings page.
Clover Health Investments, Corp (CLOV) reported $2.5B in revenue over the twelve months to Jun 30, 2026, up 54.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cash improvement reversed in FY2025 as faster growth brought back renewed losses and cash use.
FY2024’s cash recovery did not persist: operating cash flow and free cash flow were positive then, but both turned negative in FY2025. The net loss widened from$43.0M to$85.5M alongside that shift, so cash conversion deteriorated with earnings rather than remaining an accrual-only concern.
Revenue reached
The reported liquidity measure equaled 51.7 months of FY2025 operating outflow, while the current ratio was 1.5x; this indicates substantial reported liquidity alongside only moderate near-term asset coverage. Debt-to-equity was 0.8x versus 0.7x in FY2024, so financing is not dominated by debt even as equity declined.
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Clover Health Investments, Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Clover Health Investments, Corp has an operating margin of -4.4%, meaning the company loses $4 on every $100 of revenue. This results in a profitability score of 28/100. This is down from -3.3% the prior year.
Clover Health Investments, Corp's revenue surged 40.3% year-over-year to $1.9B, reflecting rapid business expansion. This strong growth earns a score of 85/100.
Clover Health Investments, Corp has a moderate D/E ratio of 0.75. This balance of debt and equity financing earns a leverage score of 53/100.
Clover Health Investments, Corp's current ratio of 1.47 indicates adequate short-term liquidity, earning a score of 40/100. The company can meet its near-term obligations, though with limited headroom.
Clover Health Investments, Corp's operations used $66.9M of cash, and capex of $2.0M added to the outflow, for a free cash flow shortfall of $69.0M. This results in a cash flow score of 18/100.
Clover Health Investments, Corp posts a -27.7% return on equity (ROE), meaning it loses $28 for every $100 of shareholders' equity. This results in a returns score of 21/100. This is down from -12.6% the prior year.
Clover Health Investments, Corp scores 3.75, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.5B) relative to total liabilities ($232.3M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Clover Health Investments, Corp passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
Clover Health Investments, Corp reported a net loss of $85.5M while operations used $66.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Clover Health Investments, Corp generated $743.2M in revenue in Q2 2026. This represents an increase of 55.6% from the same quarter a year earlier. Against the prior quarter it is down 0.8%.
Clover Health Investments, Corp's EBITDA was $28.6M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 381.0% from the same quarter a year earlier. Against the prior quarter it is up 2.6%.
Clover Health Investments, Corp reported $28.0M in net income in Q2 2026. This represents an increase of 364.7% from the same quarter a year earlier. Against the prior quarter it is up 2.4%.
Clover Health Investments, Corp earned $0.05 per diluted share (EPS) in Q2 2026. This represents an increase of 350.0% from the same quarter a year earlier. It is unchanged from the prior quarter.
Cash & Balance Sheet
Clover Health Investments, Corp generated $24.5M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 406.4% from the same quarter a year earlier. Against the prior quarter it is down 77.1%.
Clover Health Investments, Corp held $198.8M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
Clover Health Investments, Corp's operating margin was 3.8% in Q2 2026, reflecting core business profitability. This is up 6.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.
Clover Health Investments, Corp's net profit margin was 3.8% in Q2 2026, showing the share of revenue converted to profit. This is up 6.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.
Clover Health Investments, Corp's ROE was 7.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 10.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.6 percentage points.
Not reported for Q2 2026.
Capital Allocation
Clover Health Investments, Corp repurchased no shares in Q2 2026.
Clover Health Investments, Corp invested $682K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 19.9% from the same quarter a year earlier. Against the prior quarter it is down 20.1%.
Not reported for Q2 2026.
CLOV Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $743.2M+55.6% | $749.2M+62.0% | $487.7M+44.7% | $496.6M+50.1% | $477.6M+34.1% | $462.3M+33.3% | $337.0M+7.9% | $331.0M+8.2% |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $81.2M+15.6% |
| SG&A Expenses | $70.3M+45.0% | $74.6M+47.3% | $66.2M+26.5% | $49.0M+39.1% | $48.5M+9.1% | $50.7M+13.7% | $52.3M+22.4% | $35.2M-14.2% |
| Operating Income | $28.0M+365.2% | $27.3M+2245.5% | -$49.3M-129.9% | -$24.4M-177.5% | -$10.6M-246.9% | -$1.3M+94.4% | -$21.4M+66.0% | -$8.8M+73.9% |
| EBITDA | $28.6M+381.0% | $27.8M+3546.7% | -$48.9M-131.7% | -$24.0M-183.8% | -$10.2M-235.2% | -$808K+96.4% | -$21.1M+66.2% | -$8.4M+74.5% |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0 |
| Net Income | $28.0M+364.7% | $27.3M+2245.5% | -$49.3M-123.2% | -$24.4M-166.3% | -$10.6M-242.8% | -$1.3M+93.4% | -$22.1M+68.7% | -$9.2M+77.9% |
| EPS (Basic) | $0.05+350.0% | $0.05 | -$0.10-150.0% | -$0.05-150.0% | -$0.02-300.0% | $0.00+100.0% | -$0.04+71.4% | -$0.02+77.8% |
| EPS (Diluted) | $0.05+350.0% | $0.05 | -$0.10-150.0% | -$0.05-150.0% | -$0.02-300.0% | $0.00+100.0% | -$0.04+71.4% | -$0.02+77.8% |
| Diluted Shares (Avg) | 545M+7.2% | 533M+7.1% | N/A | 513M+4.6% | 509M+2.8% | 497M+2.2% | N/A | 490M+2.0% |
Not reported in any period shown, so not listed: Cost of Revenue, R&D Expenses, Income Tax.
CLOV Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $720.3M+25.3% | $697.7M+19.5% | $541.0M-6.8% | $559.7M-14.3% | $575.0M-14.7% | $583.7M-13.1% | $580.7M+1.8% | $653.0M-4.7% |
| Current Assets | $485.4M+33.8% | $448.0M+35.2% | $307.9M-10.3% | $330.9M-23.5% | $362.9M-34.0% | $331.4M-40.0% | $343.1M-19.8% | $432.7M |
| Cash & Equivalents | $198.8M+5.4% | $173.3M+11.5% | $78.3M-59.8% | $190.1M-34.0% | $188.6M-26.0% | $155.4M-25.4% | $194.5M+58.3% | $288.0M-3.7% |
| Short-Term Investments | $39.7M+265.9% | $24.2M+419.5% | $23.1M-14.3% | $11.0M-74.6% | $10.9M-90.2% | $4.7M-96.1% | $27.0M-73.2% | $43.3M-78.0% |
| Long-Term Investments | $189.4M+8.0% | $202.2M-6.6% | $187.1M-7.3% | $180.7M-1.8% | $175.5M+70.4% | $216.5M+122.9% | $201.7M+67.8% | $184.1M+81.5% |
| Total Liabilities | $344.1M+49.1% | $358.3M+44.7% | $232.3M-3.0% | $218.7M-29.6% | $230.8M-33.9% | $247.6M-34.7% | $239.6M-15.7% | $310.8M-14.4% |
| Current Liabilities | $323.3M+60.1% | $336.6M+56.1% | $208.8M-2.2% | $193.4M-30.8% | $201.9M-37.8% | $215.7M-39.5% | $213.5M-18.2% | $279.6M |
| Non-Current Liabilities | $20.7M-28.1% | $21.7M-32.1% | $23.5M-10.0% | $25.3M-19.0% | $28.9M+16.3% | $32.0M+39.6% | $26.1M+12.6% | $31.2M+108.8% |
| Total Equity | $376.3M+9.3% | $339.4M+1.0% | $308.7M-9.5% | $340.9M-0.4% | $344.2M+5.9% | $336.1M+14.9% | $341.1M+19.1% | $342.2M+6.3% |
| Retained Earnings | -$2.2B-0.8% | -$2.3B-2.6% | -$2.3B-3.9% | -$2.2B-2.7% | -$2.2B-2.0% | -$2.2B-1.2% | -$2.2B-2.0% | -$2.2B-4.4% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
CLOV Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $25.2M+365.8% | $107.9M+762.2% | -$68.2M+20.6% | $12.1M-75.8% | $5.4M-87.9% | -$16.3M-162.8% | -$85.8M+66.7% | $50.0M+366.2% |
| Depreciation & Amortization | $564K+43.1% | $515K+10.5% | $420K+22.1% | $406K+19.8% | $394K+19.4% | $466K+46.5% | $344K-49.0% | $339K-39.1% |
| Stock-Based Compensation | $8.9M-66.0% | $12.3M-53.6% | N/A | $26.1M-6.7% | $26.2M-6.1% | $26.4M-8.2% | N/A | $28.0M-15.4% |
| Capital Expenditures | $682K+19.9% | $854K+361.6% | $597K+89.5% | $692K+73.4% | $569K+43.3% | $185K-58.4% | $315K+19.3% | $399K+64.2% |
| Free Cash Flow | $24.5M+406.4% | $107.0M+749.6% | -$68.7M+20.2% | $11.4M-77.0% | $4.8M-89.1% | -$16.5M-164.6% | -$86.1M+66.7% | $49.6M+360.7% |
| Investing Cash Flow | -$32K-100.1% | -$5.1M-156.8% | -$35.0M-2331.9% | -$5.4M+55.3% | $35.6M+617.9% | $8.9M-2.8% | -$1.4M-101.7% | -$12.1M+40.3% |
| Financing Cash Flow | $416K+105.4% | -$7.9M+75.2% | -$8.6M-40.2% | -$5.3M-13.0% | -$7.8M-143.0% | -$31.7M-845.0% | -$6.1M-643.5% | -$4.7M-137.7% |
| Share Buybacks | $0 | $0-100.0% | $0 | $1K | $0-100.0% | $18.3M | $0 | $0 |
Not reported in any period shown, so not listed: Dividends Paid.
CLOV Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 24.5%+1.6pp |
| Operating Margin | 3.8%+6.0pp | 3.6%+3.9pp | -10.1%-3.7pp | -4.9%-2.3pp | -2.2%-4.2pp | -0.3%+6.3pp | -6.4%+13.8pp | -2.6%+8.3pp |
| Net Margin | 3.8%+6.0pp | 3.6%+3.9pp | -10.1%-3.5pp | -4.9%-2.1pp | -2.2%-4.3pp | -0.3%+5.3pp | -6.6%+16.0pp | -2.8%+10.8pp |
| Return on Equity | 7.4%+10.5pp | 8.1%+8.4pp | -16.0%-9.5pp | -7.1%-4.5pp | -3.1%-5.4pp | -0.4%+6.2pp | -6.5%+18.1pp | -2.7%+10.2pp |
| Return on Assets | 3.9%+5.7pp | 3.9%+4.1pp | -9.1%-5.3pp | -4.4%-3.0pp | -1.8%-2.9pp | -0.2%+2.6pp | -3.8%+8.5pp | -1.4%+4.7pp |
| Current Ratio | 1.50-0.3x | 1.33-0.2x | 1.47-0.1x | 1.71+0.2x | 1.80+0.1x | 1.540.0x | 1.610.0x | 1.55 |
| Debt-to-Equity | 0.91+0.2x | 1.06+0.3x | 0.75+0.1x | 0.64-0.3x | 0.67-0.4x | 0.74-0.6x | 0.70-0.3x | 0.91-0.2x |
| Asset Turnover | 1.03+0.2x | 1.07+0.3x | 0.90+0.3x | 0.89+0.4x | 0.83+0.3x | 0.79+0.3x | 0.580.0x | 0.51+0.1x |
| FCF Margin | 3.3%+2.3pp | 14.3%+17.8pp | -14.1%+11.5pp | 2.3%-12.7pp | 1.0%-11.4pp | -3.6%-10.9pp | -25.6%+57.1pp | 15.0%+21.2pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Clover Health Investments, Corp CLOV | FY2025 | $1.9B | -$85.5M | -4.5% | $2.5B | 41/100 |
| Progyny, Inc. PGNY | FY2025 | $1.3B | $58.5M | 4.5% | $2.1B | 69/100 |
| Alignment Healthcare, Inc. ALHC | FY2025 | $3.9B | -$724K | 0.0% | $1.7B | 55/100 |
| Oscar Health, Inc. OSCR | FY2025 | $11.7B | -$443.2M | -3.8% | $10.6B | 46/100 |
| NeueHealth, Inc. NEUE | FY2024 | $936.7M | -$134.7M | -14.4% | $60.9M | 28/100 |
| Molina Healthcare, Inc. MOH | FY2025 | $45.4B | $472.0M | 1.0% | $10.9B | 63/100 |
Where Clover Health Investments, Corp Ranks
Frequently Asked Questions
What is Clover Health Investments, Corp's annual revenue?
Clover Health Investments, Corp (CLOV) reported $1.9B in total revenue for fiscal year 2025. This represents a 40.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Clover Health Investments, Corp's revenue growing?
Clover Health Investments, Corp (CLOV) revenue grew by 40.3% year-over-year, from $1.4B to $1.9B in fiscal year 2025.
Is Clover Health Investments, Corp profitable?
No, Clover Health Investments, Corp (CLOV) reported a net income of -$85.5M in fiscal year 2025, with a net profit margin of -4.5%.
What is Clover Health Investments, Corp's EBITDA?
Clover Health Investments, Corp (CLOV) had EBITDA of -$83.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Clover Health Investments, Corp's operating margin?
Clover Health Investments, Corp (CLOV) had an operating margin of -4.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Clover Health Investments, Corp's net profit margin?
Clover Health Investments, Corp (CLOV) had a net profit margin of -4.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Clover Health Investments, Corp's return on equity (ROE)?
Clover Health Investments, Corp (CLOV) has a return on equity of -27.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Clover Health Investments, Corp's free cash flow?
Clover Health Investments, Corp (CLOV) recorded an outflow of $69.0M in free cash flow during fiscal year 2025. This represents a -307.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Clover Health Investments, Corp's operating cash flow?
Clover Health Investments, Corp (CLOV) recorded an outflow of $66.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Clover Health Investments, Corp's total assets?
Clover Health Investments, Corp (CLOV) had $541.0M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Clover Health Investments, Corp's capital expenditures?
Clover Health Investments, Corp (CLOV) invested $2.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Clover Health Investments, Corp's current ratio?
Clover Health Investments, Corp (CLOV) had a current ratio of 1.47 as of fiscal year 2025, which is considered adequate.
What is Clover Health Investments, Corp's debt-to-equity ratio?
Clover Health Investments, Corp (CLOV) had a debt-to-equity ratio of 0.75 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Clover Health Investments, Corp's return on assets (ROA)?
Clover Health Investments, Corp (CLOV) had a return on assets of -15.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Clover Health Investments, Corp's P/E ratio?
Clover Health Investments, Corp (CLOV) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $2.5B as of Oct 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Clover Health Investments, Corp's price-to-sales ratio?
Clover Health Investments, Corp (CLOV) trades at 1.0x sales, its market capitalization divided by revenue of $2.5B revenue, trailing 12 months to June 30, 2026. The market capitalization is $2.5B as of Oct 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Clover Health Investments, Corp's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Clover Health Investments, Corp (CLOV) held $288.5M in cash, cash equivalents and investments, and reported an operating cash outflow of $66.9M over that year. Dividing the one by the other, the reported balance equals about 52 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Clover Health Investments, Corp's Altman Z-Score?
Clover Health Investments, Corp (CLOV) has an Altman Z-Score of 3.75, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Clover Health Investments, Corp's Piotroski F-Score?
Clover Health Investments, Corp (CLOV) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Clover Health Investments, Corp's earnings high quality?
Clover Health Investments, Corp (CLOV) reported a net loss of $85.5M while operations used $66.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Clover Health Investments, Corp?
Clover Health Investments, Corp (CLOV) scores 41 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.